Axis Therapeutics is a company providing TCR therapies to cure cancer. It specializes in the field of immunotherapy, particularly in the area of T cell therapies. The company develops a TCR-T technology platform, to generate T-cells with higher binding affinity, specificity, express level, and persistence.